Orchid Pharma releases audio recording of earnings call

1 min read     Updated on 27 May 2026, 09:17 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Orchid Pharma Limited has released the audio recording of its analysts and investors earnings call held on May 26, 2026. The disclosure was made pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The recording confirms the call was conducted via audio conference with no video recording available.

powered bylight_fuzz_icon
41442431

*this image is generated using AI for illustrative purposes only.

Orchid Pharma Limited has made available the audio recording of its analysts and investors earnings call held on May 26, 2026. The disclosure was submitted to the National Stock Exchange of India Limited and BSE Limited pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The earnings call was conducted through an audio conference at 04:30 P.M. (IST). The company confirmed that no video recording of the proceedings is available. The audio file can be accessed via a specific link provided on the corporate website.

The filing references SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. This circular mandates the dissemination of such recordings to ensure transparency and broader access to information shared during investor interactions.

The communication was signed by Kapil Dayya, Company Secretary & Compliance Officer of Orchid Pharma Limited. The intimation serves as a formal record of the event's occurrence and the availability of the associated audio file for stakeholders.

Detail Information
Event Analysts/Investors Earnings Call
Date May 26, 2026
Time 04:30 P.M. (IST)
Format Audio Conference
Video Recording Not Available

Historical Stock Returns for Orchid Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
+4.09%+10.79%+35.41%-7.56%+12.54%-44.85%

What key guidance or strategic updates did Orchid Pharma provide regarding its pipeline for FY2027?

How might the new SEBI disclosure mandate impact investor engagement strategies for other Indian pharmaceutical companies?

What are the expected market reactions to the financial results discussed during the call?

Orchid Pharma schedules Q4FY26 earnings call on May 26

1 min read     Updated on 20 May 2026, 05:54 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Orchid Pharma Limited has scheduled an analysts and investors earnings call for May 26, 2026, to review financial results for the quarter and year ended March 31, 2026. Hosted by Systematix Institutional Equities, the session will include participation from Managing Director Manish Dhanuka, Whole Time Director Mridul Dhanuka, and CFO Sunil Kumar Gupta. Dial-in details and a Diamond Pass option are available for participants.

powered bylight_fuzz_icon
40741723

*this image is generated using AI for illustrative purposes only.

Orchid Pharma Limited has announced the schedule for its analysts and investors earnings call to discuss the financial performance for the fourth quarter and financial year ended March 31, 2026. The conference is set to take place on Tuesday, May 26, 2026, at 4:30 PM IST. The session is being hosted by Systematix Institutional Equities.

Management Participation

The company's management team will be represented by key executives during the call. The participants include Mr. Manish Dhanuka, Managing Director; Mr. Mridul Dhanuka, Whole Time Director; and Mr. Sunil Kumar Gupta, Chief Financial Officer. They will address the financial results and answer queries from analysts and investors.

Dial-in Details

Participants can join the conference call using the dial-in numbers provided below. A Diamond Pass service is also available for connection without operator assistance.

Location Dial Number Location Toll Free Number
Primary Number +91 22 6280 1297 USA 1 866 746 2133
Secondary Number +91 22 7115 8198 UK 0 808 101 1573
Singapore 800 101 2045
Hong Kong 800 964 448

Additional Information

The information regarding the earnings call will be hosted on the company's official website. The schedule is subject to change due to exigencies, and any modifications will be communicated accordingly. Investors can contact Systematix Institutional Equities for further details regarding the event.

Historical Stock Returns for Orchid Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
+4.09%+10.79%+35.41%-7.56%+12.54%-44.85%

What key revenue growth targets or pipeline milestones is Orchid Pharma's management likely to highlight for FY2027 given the competitive generics landscape?

How might Orchid Pharma's Q4 FY2026 financial results influence analyst ratings and institutional investor sentiment toward the stock in the near term?

What strategic expansions or new drug approvals could Orchid Pharma announce following the earnings call to sustain growth momentum?

More News on Orchid Pharma

1 Year Returns:+12.54%